"MedaPhase, Inc. is a clinical research company dedicated to researching and testing investigational therapies for dermatologic disease."

During the past decade, MedaPhase, Inc. conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 26 clinical trials were completed, i.e. on average, 144.4% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 14 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MedaPhase, Inc." #1 sponsor was "Peplin" with 7 trials, followed by "Galderma R&D" with 6 trials sponsored, "Pfizer" with 6 trials sponsored, "LEO Pharma" with 4 trials sponsored and "Amgen" with 4 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MedaPhase, Inc." #1 collaborator was "GlaxoSmithKline" with 3 trials as a collaborator, "TKL Research, Inc." with 2 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "MedaPhase, Inc." are "Acne Vulgaris" (10 trials), "Actinic Keratosis" (9 trials), "Psoriasis" (8 trials), "Atopic Dermatitis" (5 trials) and "Rosacea" (4 trials). Many other conditions were trialed in "MedaPhase, Inc." in a lesser frequency.

Most popular intervention types in "MedaPhase, Inc." are "Drug" (49 trials), "Other" (5 trials), "Biological" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Vehicle" (5 trials), "Vehicle gel" (4 trials), "Apremilast" (3 trials) and "Vehicle cream" (3 trials). Other intervention names were less common.

The vast majority of trials in "MedaPhase, Inc." are 50 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "MedaPhase, Inc.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in MedaPhase, Inc., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in MedaPhase, Inc., 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".